Peoples Hospital Of Longhua New District Shenzhen

Shenzhen, China

Peoples Hospital Of Longhua New District Shenzhen

Shenzhen, China

Time filter

Source Type

Tan F.,Shanghai Skin Disease Hospital | Mo X.-H.,Shanghai Skin Disease Hospital | Zhao J.,Karolinska University Hospital | Liang H.,Peoples Hospital Of Longhua New District Shenzhen | And 2 more authors.
Journal of Nanoparticle Research | Year: 2017

Antiangiogenesis has been widely accepted as an attractive strategy to combat tumor growth, invasion, and metastasis. An actively targeting nanoparticle-based drug delivery system (nano-DDS) would provide an alternative method to achieve antiangiogenic antitumor therapy. In the present study, our group fabricated novel nano-DDS, TLTYTWS (TS) peptide-modified poly(ethylene glycol)–poly(lactic acid) (PEG–PLA) nanoparticles (TS-NPs) encapsulating a drug with antiangiogenic potential, paclitaxel (Ptx) (TS-Ptx-NPs). The nanoparticles were uniformly spherical and had a unimodal particle size distribution and slightly negative zeta potential. TS-NPs accumulated significantly in human umbilical vein endothelial cells (HUVECs) via energy-dependent and caveolae- and lipid raft-mediated endocytosis and improved the antiproliferative, antimigratory, and antitube-forming abilities of paclitaxel in vitro. Following intravenous administration, TS-Ptx-NPs presented favorable pharmacokinetic profiles. Melanoma distribution assays confirmed that TS-NPs achieved higher accumulation and penetration at melanoma sites. These results collectively indicated that TLTYTWS-decorated nanoparticles can be considered to be a promising nano-DDS for chemotherapies targeting tumor angiogenesis and have great potential to improve the efficacy of antiangiogenic therapy in melanoma tumor-bearing nude mice. © 2017, Springer Science+Business Media Dordrecht.

Loading Peoples Hospital Of Longhua New District Shenzhen collaborators
Loading Peoples Hospital Of Longhua New District Shenzhen collaborators